As Novo Nordisk and Pfizer fight over a promising GLP-1 pipeline at Metsera, Amgen is staying the course on its ...
Q3 2025 Earnings Call November 6, 2025 8:30 AM ESTCompany ParticipantsVipin Garg - President, CEO & DirectorLinda Richardson ...
In the United States, 1 in every 250 people has inherited a genetic variant that leads to dangerously high cholesterol levels ...
A CRISPR-based gene therapy showed improvement in lipids in difficult-to-treat patients, but one study raised flags after a ...
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.
Most people track cholesterol and sugar to guard their hearts, but cardiologists now warn of a lesser-known threat — ...
News-Medical.Net on MSN
Major gaps found in cholesterol management for young adults
Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or "bad" cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a ...
Global growth is projected at –4.9 percent in 2020, 1.9 percentage points below the April 2020 World Economic Outlook (WEO) forecast. The COVID-19 pandemic has had a more negative impact on activity ...
A senior neurologist from Apollo Hospitals, Dr. Sudhir Kumar, emphasized that visible fitness markers like weight loss or ...
No one disputes that firms have to make organizational changes when the business environment demands them. But the idea that a firm might want change for its own sake often provokes skepticism. Why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback